Researchers have successfully engineered multi-zonal liver organoids from human pluripotent stem cells, mimicking the liver's spatial architecture.
The challenge of replicating the liver's zonal heterogeneity in vitro has been addressed through self-assembling organoids derived from human induced pluripotent stem cells.
Ascorbate and bilirubin were used to differentiate hepatic progenitors into zone-specific phenotypes, creating a spatially ordered microtissue.
The organoids authentically recapitulate the multi-zonal hepatic architecture, allowing for physiologically relevant studies in liver biology and regenerative medicine.
Single-nucleus RNA sequencing highlighted the gene expression landscapes across individual nuclei within the organoids, revealing zonal identities.
Epigenetic analyses uncovered regulatory mechanisms involving molecules like ascorbate and bilirubin that shape chromatin accessibility and gene expression specific to zonal phenotypes.
The zonally patterned hepatic organoids demonstrated zone-specific metabolic activities, paving the way for accurate modeling of liver metabolism and diseases.
Transplantation of human organoids improved survival outcomes in rats with liver injury, showcasing the potential for novel cell therapies in chronic liver diseases.
The model offers insights into liver development, zonal specification, drug toxicity screening, and disease pathogenesis.
This innovative technology opens new possibilities for drug discovery, personalized medicine, and advancing liver health through bioengineered grafts.